PA 15-219—sSB 28

General Law Committee

Public Health Committee

AN ACT CONCERNING MANUFACTURER NAMES, MEDWATCH REPORTING INFORMATION AND BRAND NAMES ON GENERIC DRUG CONTAINERS

SUMMARY: This act expands the information pharmacists must provide when dispensing generic prescription drugs.

For drugs sold only by generic name, the act requires pharmacists to include the (1) manufacturer's name and (2) website and toll-free telephone number of MedWatch, the U. S. Food and Drug Administration's drug safety and reporting program. This information may be placed on the prescription container's label, packaging, or receipt.

If a pharmacist substitutes a generic name drug for a brand name drug, the act requires the pharmacist to include on the prescription container's label the name of the (1) generic drug in the container and (2) brand name drug prescribed. (Pharmacists are generally allowed to substitute a generic drug for a prescribed drug if it is of the same strength, quantity, dose, and dosage form and the pharmacist believes it is therapeutically equivalent (CGS 20-619). )

The law already requires pharmacists to include, on all prescription drug labels, (1) the quantity of the prescribed drug, (2) an expiration date, and (3) any other information required by law.

EFFECTIVE DATE: January 1, 2016

OLR Tracking: KLM; RP; PF; BS